Details for New Drug Application (NDA): 019880

✉ Email this page to a colleague

NDA 019880 describes PARAPLATIN, which is a drug marketed by Corden Pharma and Cordenpharma and is included in two NDAs. Additional details are available on the PARAPLATIN profile page.

The generic ingredient in PARAPLATIN is carboplatin. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the carboplatin profile page.

Summary for 019880

Tradename:	PARAPLATIN
Applicant:	Corden Pharma
Ingredient:	carboplatin
Patents:	0

Medical Subject Heading (MeSH) Categories for 019880

Antineoplastic Agents
Cross-Linking Reagents

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	50MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Mar 3, 1989	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	150MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Mar 3, 1989	TE:		RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	450MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Mar 3, 1989	TE:		RLD:	Yes

Expired US Patents for NDA 019880

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Corden Pharma	PARAPLATIN	carboplatin	INJECTABLE;INJECTION	019880-001	Mar 3, 1989	4,657,927*PED	⤷ Subscribe
Corden Pharma	PARAPLATIN	carboplatin	INJECTABLE;INJECTION	019880-003	Mar 3, 1989	4,657,927*PED	⤷ Subscribe
Corden Pharma	PARAPLATIN	carboplatin	INJECTABLE;INJECTION	019880-002	Mar 3, 1989	4,657,927*PED	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.